179 related articles for article (PubMed ID: 29426306)
1. Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020.
Guzzinati S; Virdone S; De Angelis R; Panato C; Buzzoni C; Capocaccia R; Francisci S; Gigli A; Zorzi M; Tagliabue G; Serraino D; Falcini F; Casella C; Russo AG; Stracci F; Caruso B; Michiara M; Caiazzo AL; Castaing M; Ferretti S; Mangone L; Rudisi G; Sensi F; Mazzoleni G; Pannozzo F; Tumino R; Fusco M; Ricci P; Gola G; Giacomin A; Tisano F; Candela G; Fanetti AC; Pala F; Sardo AS; Rugge M; Botta L; Dal Maso L
BMC Cancer; 2018 Feb; 18(1):169. PubMed ID: 29426306
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
AIRTUM Working Group
Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients.
AIRTUM Working Group
Epidemiol Prev; 2010; 34(5-6 Suppl 2):1-188. PubMed ID: 21220827
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
6. An estimate of the number of people in Italy living after a childhood cancer.
Francisci S; Guzzinati S; Dal Maso L; Sacerdote C; Buzzoni C; Gigli A;
Int J Cancer; 2017 Jun; 140(11):2444-2450. PubMed ID: 28233308
[TBL] [Abstract][Full Text] [Related]
7. Cancer prevalence estimates in Italy from 1970 to 2010.
De Angelis R; Grande E; Inghelmann R; Francisci S; Micheli A; Baili P; Meneghini E; Capocaccia R; Verdecchia A
Tumori; 2007; 93(4):392-7. PubMed ID: 17899871
[TBL] [Abstract][Full Text] [Related]
8. Italian cancer figures--report 2006: 1. Incidence, mortality and estimates.
AIRT Working Group
Epidemiol Prev; 2006; 30(1 Suppl 2):8-10, 12-28, 30-101 passim. PubMed ID: 16826725
[TBL] [Abstract][Full Text] [Related]
9. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care.
de Moor JS; Mariotto AB; Parry C; Alfano CM; Padgett L; Kent EE; Forsythe L; Scoppa S; Hachey M; Rowland JH
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):561-70. PubMed ID: 23535024
[TBL] [Abstract][Full Text] [Related]
10. Projections of cancer prevalence in the United Kingdom, 2010-2040.
Maddams J; Utley M; Møller H
Br J Cancer; 2012 Sep; 107(7):1195-202. PubMed ID: 22892390
[TBL] [Abstract][Full Text] [Related]
11. Cancer prevalence by phase of care: an indicator for assessing health service needs.
Gigli A; Francisci S; Guzzinati S; Hall A; Hachey M; Scoppa S; Mariotto A
Tumori; 2021 Aug; 107(4):311-317. PubMed ID: 33095121
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
13. Cancer prevalence in Italian regions with local cancer registries.
Mariotto A; Dally LG; Micheli A; Canario F; Verdecchia A
Tumori; 1999; 85(5):400-7. PubMed ID: 10665857
[TBL] [Abstract][Full Text] [Related]
14. Cancer prevalence in Italy: an analysis of geographic variability.
Guzzinati S; Buzzoni C; De Angelis R; Rosso S; Tagliabue G; Vercelli M; Pannozzo F; Mangone L; Piffer S; Fusco M; Giacomin A; Traina A; Capocaccia R; Dal Maso L; Crocetti E;
Cancer Causes Control; 2012 Sep; 23(9):1497-510. PubMed ID: 22821425
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Regional estimates of all cancer malignancies in Italy.
Grande E; Inghelmann R; Francisci S; Verdecchia A; Micheli A; Baili P; Capocaccia R; De Angelis R
Tumori; 2007; 93(4):345-51. PubMed ID: 17899864
[TBL] [Abstract][Full Text] [Related]
17. Cancer prevalence estimates in Europe at the beginning of 2000.
Gatta G; Mallone S; van der Zwan JM; Trama A; Siesling S; Capocaccia R;
Ann Oncol; 2013 Jun; 24(6):1660-6. PubMed ID: 23553062
[TBL] [Abstract][Full Text] [Related]
18. The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project.
Trama A; Mallone S; Ferretti S; Meduri F; Capocaccia R; Gatta G;
Tumori; 2012; 98(5):550-8. PubMed ID: 23235748
[TBL] [Abstract][Full Text] [Related]
19. Cancer prevalence in the elderly. ITAPREVAL Working Group.
Vercelli M; Quaglia A; Parodi S; Crosignani P
Tumori; 1999; 85(5):391-9. PubMed ID: 10665856
[TBL] [Abstract][Full Text] [Related]
20. Cancer estimates up to 2015 in Friuli Venezia Giulia.
Zucchetto A; Serraino D; Dal Maso L; Birri S; Francisci S; Zigon G; De Angelis R
Tumori; 2013; 99(3):318-26. PubMed ID: 24158060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
